South America Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)

Code: TIPRE00025458 | Pages: 110 | Industry: Pharmaceuticals | Date: Oct 2021 | Type: Regional

Market Introduction

South America (SAM) region consists of Brazil, Argentina, and Rest of South America. The countries are likely to offer growth opportunities due to growing domestic’s production of pharmaceutical and biopharmaceutical production, increasing support from governments, and rising research and developments. Brazil’s 70% of pharmaceutical business is dependent on imports of pharmaceutical products. For instance, in 2019, medicines worth US$ 7 billion were imported, among which biological medicines were worth US$ 2 billion, i.e., 30% of the total import. However, the COVID-19 pandemic has offered vital growth opportunities for the domestic production of medicines to Brazil and various countries across the world. Associations in Brazil such as the Brazilian Association of Generic Medicines Industries (PróGenlicos) and FarmaBrasil Group (GFB) state that the country can produce nearly 75% of the total demand for medicines in the country. Therefore, it is expected to increase the demand for pharmaceutical intermediates in the country. Also, in 2019, the country has imported a significant number of biological products or immunotherapeutic drugs worth US$ 1 billion. Therefore, it is expected that investing a huge amount in importing pharmaceutical products. The country can invest in the domestic production of medicines and will only incur in importing pharmaceutical intermediates. In addition, the companies operating in the country that are associated with FarmaBrasil Group have commitments, through the Partnerships for Productive Development (PDPs), to produce medicines domestically, including bevacizumab, palivizumab, infliximab, betainterferone 1A, and insulin, among others. Thus, it is expected that such strategic moves for domestic production will enhance the demand for pharmaceutical intermediate and eventually lead to market growth in the following years. Rise in prevalence of chronic diseases and infectious diseases is the major factor driving the growth of the SAM pharmaceutical intermediates market.

The South America region includes countries such as Brazil and Argentina. These countries have also registered a significant number of positive coronavirus infection cases. In the South American region, the virus continues to spread aggressively in Brazil, Peru, and Chile. Many South American countries have faced shortages of resources to manufacture and supply medical products. Some of the hard-hit countries such as Brazil, where case number surpassed 13,521,409, and Argentina, the case recorded as 2,551,999 as of April 2021. It is expected that the region is likely to impose a second lockdown, which will eventually hamper the healthcare industry in the area. COVID-19 continues to have a tremendous impact on the region. Although Peru established one of the strictest lockdowns in the South America region, it suffered the highest mortality rate due to COVID-19. The coronavirus pandemic has become an enormous challenge to this region, as they are low-cost regions. The Brazilian pharmaceutical industry is facing challenges of trying to contain the COVID-19 pandemic while dealing with enormous cost pressures. In Brazil, the rise in the dollar has made importing APIs more expensive and also there is increase in logistics costs, due to the reduction in air traffic, with the consequent upsurge in freight costs. Additionally, there is also significant increase in the prices of raw materials, inputs and finished products. These factors are likely to have negative impact on the market.


Get more information on this report :



Market Overview and Dynamics

The pharmaceutical intermediates market in SAM is expected to grow from US$ 997.56 million in 2021 to US$ 1,197.02 million by 2028; it is estimated to grow at a CAGR of 2.6% from 2021 to 2028. Countries such as Argentina and Chile are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Low manufacturing and operating costs in these countries are key factors driving the pharmaceutical manufacturing business in the region. Recent growth in the pharmaceutical industry indicate a positive outlook for the pharmaceutical intermediates market. Flourishing domestic pharmaceutical market in the region and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities, further boosting the growth of the market. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies across SAM region.

Key Market Segments

The SAM pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in SAM are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; and Sanofi are among others.

Reasons to buy report

  • To understand the SAM pharmaceutical intermediates market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM pharmaceutical intermediates market
  • Efficiently plan M&A and partnership deals in SAM pharmaceutical intermediates market by identifying market segments with the most promising probable sales  
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM pharmaceutical intermediates market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in SAM region.

SAM Pharmaceutical Intermediates Market Segmentation

SAM Pharmaceutical Intermediates Market -By Type

  • GMP
  • Non GMP

SAM Pharmaceutical Intermediates Market -By Application

  • Antibiotics
  • Antipyretic analgesics
  • Vitamins
  • Others

SAM Pharmaceutical Intermediates Market -By Distribution Channel

  • Distributor
  • Direct Sales

SAM Pharmaceutical Intermediates Market -By Country

  • Brazil
  • Argentina
  • Rest of SAM

SAM Pharmaceutical Intermediates Market -Company Profiles

  • BASF SE
  • chiracon GmbH
  • Codexis
  • Dishman Carbogen Amcis Ltd
  • Midas Pharma GmbH
  • Pfizer Inc.
  • Sanofi

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Pharmaceutical Intermediates Market – By Type

1.3.2        SAM Pharmaceutical Intermediates Market – By Application

1.3.3        SAM Pharmaceutical Intermediates Market – By Distribution Channel

1.3.4        SAM Pharmaceutical Intermediates Market– By Country

2.           SAM Pharmaceutical Intermediates Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Pharmaceutical Intermediates Market– Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Expert Opinion

5.           SAM Pharmaceutical Intermediates Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Chronic Diseases and Infectious Diseases

5.1.2        Escalating R&D Investments by Pharmaceutical Companies

5.2         Market Restraints

5.2.1        High Cost of Manufacturing

5.3         Market Opportunities

5.3.1        Developing Markets

5.4         Future Trends

5.4.1        Increasing Adoption of AI-based Tools for Drug Discovery

5.5         Impact Analysis

6.           Pharmaceutical Intermediates Market– SAM Analysis

6.1         SAM Pharmaceutical Intermediates Market Revenue Forecast and Analysis

7.           SAM Pharmaceutical Intermediates Market Analysis – By Type

7.1         Overview

7.2         Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

7.3         GMP

7.3.1        Overview

7.3.2        GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Non GMP

7.4.1        Overview

7.4.2        Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.           SAM Pharmaceutical Intermediates Market Analysis – By Application

8.1         Overview

8.2         Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

8.3         Antibiotics

8.3.1        Overview

8.3.2        Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Antipyretic Analgesics

8.4.1        Overview

8.4.2        Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Vitamins

8.5.1        Overview

8.5.2        Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Other

8.6.1        Overview

8.6.2        Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.           SAM Pharmaceutical Intermediates Market– By Distribution Channel

9.1         Overview

9.2         Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

9.3         Distributor

9.3.1        Overview

9.3.2        Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Direct Sales

9.4.1        Overview

9.4.2        Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

10.        SAM Pharmaceutical Intermediates Market – Country Analysis

10.1.1     South America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.1.2     Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1       Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2       Brazil: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.2.3       Brazil: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.2.4       Brazil: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.3     Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1       Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2       Argentina: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.3.3       Argentina: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.3.4       Argentina: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.4     Rest of South America: Pharmaceutical Intermediates Market- Revenue and Forecasts to 2028 (USD Million)

10.1.4.1       Rest of South America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2       Rest of South America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.4.3       Rest of South America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.4.4       Rest of South America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Impact of COVID-19 Pandemic on SAM Pharmaceutical Intermediates Market

12.        SAM Pharmaceutical Intermediates Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Pfizer Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Sanofi

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BASF SE

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dishman Carbogen Amcis Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Codexis

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Midas Pharma GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      chiracon GmbH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             SAM Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             Rest of South America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of South America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          Rest of South America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Organic Developments Done By Companies

Table 12.          Inorganic Developments Done By Companies

Table 13.          Glossary of Terms, SAM Pharmaceutical Intermediates Market

LIST OF FIGURES

Figure 1.           SAM Pharmaceutical Intermediates Market Segmentation

Figure 2.           SAM Pharmaceutical Intermediates Segmentation, By Country

Figure 3.           SAM Pharmaceutical Intermediates Market Overview

Figure 4.           GMP Held Largest Share of Type Segment in SAM Pharmaceutical Intermediates Market

Figure 5.           Brazil to Show Remarkable Growth During Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           SAM Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints

Figure 9.           SAM Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        SAM Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

Figure 11.        SAM GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        SAM Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        SAM Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

Figure 14.        SAM Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        SAM Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        SAM Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        SAM Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        SAM Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

Figure 19.        SAM Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        SAM Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        South America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 22.        South America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 23.        Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Rest of South America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in SAM Market

 




  1. BASF SE
  2. chiracon GmbH
  3. Codexis
  4. Dishman Carbogen Amcis Ltd
  5. Midas Pharma GmbH
  6. Pfizer Inc.
  7. Sanofi
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000